Endometrial carcinoma with ectopic human chorionic gonadotropin expression

• Aggressive course and treatment resistance characterize ectopic human chorionic gonadotropin. • Recurrence of endometrial cancer with ectopic hCG was treated with brachytherapy and EMACO. • The serum hCG level can serve as a marker in tumors with ectopic hCG expression.

Detalles Bibliográficos
Autores principales: Lee, Regina, Pattillo, Roland, Bouzyk, Mark, Oprea-Ilies, Gabriela, Matthews, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442660/
https://www.ncbi.nlm.nih.gov/pubmed/26076157
http://dx.doi.org/10.1016/j.gore.2015.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442660/
https://www.ncbi.nlm.nih.gov/pubmed/26076157
http://dx.doi.org/10.1016/j.gore.2015.03.001

Ejemplares similares